✦ LIBER ✦

Predictors for severe cardiac complications after hematopoietic stem cell transplantation

✍ Scribed by Sakata-Yanagimoto, M; Kanda, Y; Nakagawa, M; Asano-Mori, Y; Kandabashi, K; Izutsu, K; Imai, Y; Hangaishi, A; Kurokawa, M; Tsujino, S

Book ID: 110014150
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 130 KB
Volume: 33
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1704487

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hematopoietic stem cell transplantation

Hematopoietic stem cell transplantation for severe rheumatoid arthritis

✍ Moore, J J; Snowden, J; Pavletic, S; Barr, W; Burt, R 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

Cardiac complications after haploidentic

Cardiac complications after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab

✍ Oshima, K; Sakata-Yanagimoto, M; Asano-Mori, Y; Izutsu, K; Watanabe, T; Shoda, E 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

Hematopoietic stem cell transplantation

Hematopoietic stem cell transplantation for severe Crohn's disease

✍ Craig, R M; Traynor, A; Oyama, Y; Burt, R K 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

Cardiac systolic function before and aft

Cardiac systolic function before and after hematopoietic stem cell transplantation

✍ Lehmann, S; Isberg, B; Ljungman, P; Paul, C 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 60 KB

Hematopoietic stem cell transplantation

Hematopoietic stem cell transplantation for severe combined immune deficiency

✍ Kenneth I. Weinberg; Neena Kapoor; Ami J. Shah; Gay M. Crooks; Donald B. Kohn; R 📂 Article 📅 2001 🏛 Current Science Inc. 🌐 English ⚖ 183 KB

Predictors of prolonged survival after a

Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma

✍ Qaiser Bashir; Hassan Khan; Robert Z. Orlowski; Ali Imran Amjad; Nina Shah; Simr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 746 KB

## Abstract A total of 149 patients with multiple myeloma (MM) who received allogeneic hematopoietic stem cell transplantation (allo‐HCT) with myeloablative (MAC; __n__ = 38) or reduced‐intensity conditioning (RIC; __n__ = 110) regimens at MD Anderson Cancer Center were evaluated. Of the total, 120